GENOMICS AND PRECISION MEDICINE

Governance-native AI infrastructure for genomic testing laboratories, precision oncology programs, and whole-genome analysis platforms

Constitutional Runtime

Who this is for

Genomic testing laboratory leadership, precision oncology program directors, whole-genome analysis platform operators, laboratory-developed test workflow owners, and clinical bioinformatics functions deploying AI where a wrong answer touches a variant interpretation draft, a report narrative, a clinician-facing communication, or a quality documentation record. Regulatory posture around genomic testing (laboratory operator responsibility) sits outside this surface. This surface is capability-mapped for the genomics ecosystem. It does not represent clinical validation, regulatory approval, or test performance certification.

  • Genomic testing laboratory leadership and medical directors
  • Precision oncology and targeted therapy program directors
  • Whole-genome and whole-exome analysis platform operators
  • Laboratory-developed test (LDT) workflow and quality functions
  • Clinical bioinformatics and variant curation teams

Capability surface

Constitutional runtime

The PRAXIS 7-Gate pipeline enforces governance on every AI action. It stops when unsure. Evidence is mandatory. Defaults deny rather than guess. Variant interpretation support, report drafting, and clinician communication inherit this posture by construction, not by policy overlay.

Variant interpretation evidence

Every AI action that drafts, summarizes, or reasons over variant interpretation notes, annotation summaries, or curated evidence passes through a tamper-evident, SHA-256 hash-chained evidence store. Board review, quality audit, and post-report investigation trace by default, not retrofit. The clinical decision remains with the qualified laboratory professional.

Report drafting posture

AI-assisted report narrative drafting, technical summary generation, and clinician-facing language calibration pass through deterministic guardrails at the runtime layer. Uncertainty disclosure, limitation statements, and jurisdictional labeling boundaries run as constitutional gates rather than downstream review overlays.

Clinician communication

AI-assisted clinician communication drafting, ordering-provider follow-up, and referral-network correspondence carry the same evidence chain as the surface they act on. Policy application, exception escalation, and evidence retrieval reach one authoritative record across the reporting lifecycle.

Quality documentation synthesis

Quality management documentation, laboratory-developed test workflow narratives, and internal audit-support drafting pass through the constitutional runtime. Laboratory-specific procedures, jurisdictional documentation obligations, and patient-privacy boundaries are enforced at the runtime layer with the same sealed evidence used across the estate.

Sovereign deployment

On-premise, air-gapped, or private-cloud sovereign deployment for laboratories that cannot exfiltrate patient sequence records, variant curation inputs, or protected health information to a vendor cloud. Evidence store and constitutional runtime run inside the boundary you already operate.

Where governance meets the genomics surface

Genomic AI applications compound risk when governance is retrofitted. ETHRAEON is designed for the classes of decision where clinical trust, quality posture, and audit trail all matter. Clinical judgment and test performance remain the responsibility of the laboratory operator and the qualified professional signing the report.

  • Variant interpretation drafting and evidence synthesis. Every AI-assisted action against a variant note, annotation summary, or curated-evidence draft carries sealed provenance: input state, policy version, model version, guardrail state, and human authority for exception cases.
  • Report narrative generation. AI-assisted report drafting, technical summary generation, and clinician-facing language calibration pass through the constitutional runtime with uncertainty disclosure and limitation-statement guardrails enforced by construction.
  • Clinician communication and referral correspondence. Ordering-provider follow-up drafting, referral-network correspondence, and clinical liaison support carry hash-chained provenance across policy version, report history, and prior correspondence.
  • Quality documentation and internal audit support. Laboratory quality documentation drafts, workflow narratives, and internal audit-support materials record the decision chain from raw input to the surface a reader receives.

Proof surface

ETHRAEON runs its own operations under constitutional governance. 300 plus production surfaces, 700 plus governance directives executed and evidenced, a hash-chained evidence store, and a substrate registry that reports live status. The infrastructure is the demonstration.

Engagement

Genomics engagements start with a governance briefing scoped to your testing footprint, your quality and regulatory posture, and your current AI deployment surface across interpretation, reporting, and clinician communication. The briefing produces a written architecture assessment and a deployment path proposal. From there: pilot, evidenced production integration, or sovereign private-cloud install.

Portfolio anchors

ETHRAEON is a constitutional runtime and evidence control layer. Portfolio posture: 16 U.S. provisional filings, 73 specifications, 9 families. Public claims are calibrated. AGI-class and ASI-class positioning is architectural, not an achievement claim. This surface describes commercial capability posture. It is not a representation of clinical validation, regulatory approval, or test performance certification.